William U. Shipley

34.8k citations

401 papers · 23.8k indexed · 11 hit papers · h-index 79

Impact in

Radiation top 0.02%
- Advanced Radiotherapy Techniques
Urology top 0.05%
- Urological Disorders and Treatments

Papers in

Radiation 94
- Advanced Radiotherapy Techniques 94
Urology 69
- Urological Disorders and Treatments 64

Co-authors: Anthony L. Zietman Howard M. Sandler Donald S. Kaufman Gerald E. Hanks Howard D. Thames Jason A. Efstathiou Niall M. Heney Mack Roach
Journals: International Journal of Radiation Oncology*Biology*Physics (158 papers)Journal of Clinical Oncology (49 papers)The Journal of Urology (40 papers)Cancer (22 papers)Urology (15 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

William U. Shipley

390 papers receiving 23.1k citations

Hit Papers

11 papers align trajectories log scale

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience 2017 · 252 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 European Urology
2014 Journal of Clinical Oncology
2011 New England Journal of Medicine
2010 Journal of Clinical Oncology
2009 The Lancet
2008 Journal of Clinical Oncology
2006 International Journal of Radiation Oncology*Biology*Physics
2005 JAMA
2003 Journal of Clinical Oncology
2000 International Journal of Radiation Oncology*Biology*Physics
1997 Journal of Clinical Oncology

Peers

Countries citing papers authored by William U. Shipley

Since Specialization

Citations

This map shows the geographic impact of William U. Shipley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William U. Shipley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William U. Shipley more than expected).

Fields of papers citing papers by William U. Shipley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William U. Shipley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William U. Shipley. The network helps show where William U. Shipley may publish in the future.

Co-authors

The 25 scholars most cited alongside William U. Shipley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William U. Shipley Line = papers co-authored together William U. Shipley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712—A Randomized Phase II Trial Journal of Clinical Oncology ·John J. Coen, Peixin Zhang, Philip J. Saylor, Cheryl T. Lee, Chin‐Lee Wu, William A. Parker, قبادیان رسول, Anthony L. Zietman, Jason A. Efstathiou, Ashesh B. Jani, Ömer Küçük, Luís Souhami, Joseph P. Rodgers, Howard M. Sandler, William U. Shipley	2018	97
2	The Impact of MRE11 in Nuclear to Cytoplasmic Ratio on Outcomes in Muscle Invasive Bladder Cancer: an Analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233. International Journal of Radiation OncologyBiologyPhysics ·Anthony Magliocco, Jennifer Moughan, Jeffry Simko, Jason A. Efstathiou, Phillip J. Gray, Michael P. Hagan, David W. Kaufman, William Tester, Anthony L. Zietman, Susan McCarthy, Alan C. Hartford, Chanerin Maneechansook, Seth A. Rosenthal, Vandana Munjal, Richard H. Greenberg, Matilde Paulina Sinche Cueva, Mark E. Augspurger, John A. Keech, Kathryn Winter, William U. Shipley	2017	5
3	Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base Urologic Oncology Seminars and Original Investigations ·Trevor J. Royce, Chun Chieh Lin, Phillip J. Gray, William U. Shipley, Ahmedin Jemal, Jason A. Efstathiou	2017	41
4	Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy European Urology ·Ross Krasnow, Michael Drumm, Hannah Roberts, Andrzej Niemierko, Chin‐Lee Wu, Shulin Wu, Jing Zhang, Niall M. Heney, Matthew Wszolek, Michael L. Blute, Adam S. Feldman, Richard J. Lee, Anthony L. Zietman, William U. Shipley, Jason A. Efstathiou	2016	50
5	Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233 Journal of Clinical Oncology ·Raymond H. Mak, Daniel Hunt, William U. Shipley, Jason A. Efstathiou, William Tester, Michael P. Hagan, Donald S. Kaufman, Niall M. Heney, Anthony L. Zietman Hit paper breakdown →	2014	294
6	Adjuvant radiation therapy for early stage seminoma: Proton versus photon planning comparison and modeling of second cancer risk Radiotherapy and Oncology ·Jason A. Efstathiou, Jonathan J. Paly, Hsiao‐Ming Lu, B Athar, M. Moteabbed, Andrzej Niemierko, Judith Adams, Justin E. Bekelman, William U. Shipley, Anthony L. Zietman, Harald Paganetti	2012	28
7	Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience European Urology ·Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, Niall M. Heney, Donald S. Kaufman, Andrzej Niemierko, John J. Coen, Heath Jones, Jonathan J. Paly, Francis J. McGovern, Anthony L. Zietman	2011	293
8	The importance of combined radiation and endocrine therapy in locally advanced prostate cancer Asian Journal of Andrology ·Phillip J. Gray, William U. Shipley	2011	1
9	The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02 Clinical Cancer Research ·Alan Pollack, Kyounghwa Bae, Li‐Yan Khor, Tahseen Al‐Saleem, M. Elizabeth H. Hammond, Varagur Venkatesan, Roger W. Byhardt, Sucha O. Asbell, William U. Shipley, Howard M. Sandler	2009	24
10	Diabetes and Mortality in Men With Locally Advanced Prostate Cancer: RTOG 92-02 Journal of Clinical Oncology ·Matthew R. Smith, Kyounghwa Bae, Jason A. Efstathiou, Gerald E. Hanks, Miljenko V. Pilepich, Howard M. Sandler, William U. Shipley	2008	47
11	Long-Term Treatment Sequelae After External Beam Irradiation With or Without Hormonal Manipulation for Adenocarcinoma of the Prostate: Analysis of Radiation Therapy Oncology Group Studies 85-31, 86-10, and 92-02 International Journal of Radiation OncologyBiologyPhysics ·C.A. Lawton, T PARDOE, Miljenko V. Pilepich, Gerald E. Hanks, William U. Shipley	2007	51
12	Whole-pelvis, “mini-pelvis,” or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial International Journal of Radiation OncologyBiologyPhysics ·Mack Roach, Michelle DeSilvio, Richard K. Valicenti, David J. Grignon, Sucha O. Asbell, C.A. Lawton, Charles R. Thomas, William U. Shipley	2006	141
13	Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10 International Journal of Radiation OncologyBiologyPhysics ·William U. Shipley, Michelle DeSilvio, M.V. Pilepich, Mack Roach, Harvey B. Wolkov, William T. Sause, Philip Rubin, C.A. Lawton	2006	38
14	Increasing external beam dose for T1–T2 prostate cancer: Effect on risk groups International Journal of Radiation OncologyBiologyPhysics ·Howard D. Thames, Deborah A. Kuban, Michelle DeSilvio, Larry B. Levy, Eric M. Horwitz, Patrick A. Kupelian, Alvaro A. Martinez, Jeff M. Michalski, Thomas M. Pisansky, Howard M. Sandler, William U. Shipley, Michael J. Zeléfsky, Anthony L. Zietman	2006	16
15	RTOG 97-06: Initial report of a Phase I–II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy International Journal of Radiation OncologyBiologyPhysics ·Michael P. Hagan, Kathryn Winter, Donald S. Kaufman, Zev Wajsman, Anthony L. Zietman, N.M. Heney, Leonard M. Toonkel, Christopher U. Jones, John D. Roberts, William U. Shipley	2003	152
16	Radiation Therapy for Clinically Localized Prostate Cancer JAMA ·William U. Shipley, Howard D. Thames, Howard M. Sandler, Gerald E. Hanks, Anthony L. Zietman, Carlos A. Pérez, Deborah A. Kuban, Steven Hancock, Ю. С. Липатов	1999	350
17	Management of Carcinoma of the Bladder American Journal of Clinical Oncology ·Zbigniew Petrovich, Luc Baert, Stuart D. Boyd, Luther W. Brady, V. Schlünssen, G. H. Krauch, G. Jakse, Peter A. Jones, Adrian P.M. van der Meijden, Raymond Oyen, Hendrik Van Poppel, Marvin Rotman, Rolf Sauer, William U. Shipley, Eila C. Skinner	1998	15
18	Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. Journal of Clinical Oncology ·William Tester, Richard Caplan, John Heaney, Peter Venner, Richard Whittington, Roger W. Byhardt, Lawrence D. True, William U. Shipley	1996	201
19	Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group Urology ·Miljenko V. Pilepich, William T. Sause, William U. Shipley, John M. Krall, C.A. Lawton, David Grignon, Muhyi Al‐Sarraf, Ross A. Abrams, Richard Caplan, Madhu J. John, Marvin Rotman, Ady Levy, R. L. Scotte Doggett, P. Rubin, Mark S. Soloway	1995	393
20	THE STATUS OF BLADDER‐PRESERVING THERAPEUTIC STRATEGIES IN THE MANAGEMENT OF PATIENTS WITH MUSCLE‐INVASIVE BLADDER CANCER International Journal of Urology ·Kenkichi Koiso, William U. Shipley, F. Keuppens, L. Baert, R. Hall, M’Liss A. Hudson, Saad Khoury, Yōko Kubota, Yoshinobu Kubota, Hendrik Van Poppel	1995	11

About William U. Shipley

William U. Shipley is a scholar working on Radiation, Urology, Pulmonary and Respiratory Medicine, Surgery and Biotechnology, having authored 401 papers that have together received 23.8k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (173 papers), Prostate Cancer Diagnosis and Treatment (152 papers), Prostate Cancer Treatment and Research (145 papers), Urinary and Genital Oncology Studies (129 papers), Advanced Radiotherapy Techniques (94 papers), Urological Disorders and Treatments (64 papers), Urologic and reproductive health conditions (21 papers) and Effects of Radiation Exposure (20 papers). The work is most often cited by research in Radiation (5.4k citations), Urology (3.7k citations), Pulmonary and Respiratory Medicine (14.2k citations), Surgery (9.9k citations) and Oncology (3.8k citations). William U. Shipley has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Anthony L. Zietman, Howard M. Sandler, Donald S. Kaufman, Gerald E. Hanks, Howard D. Thames, Jason A. Efstathiou, Niall M. Heney, Mack Roach, John J. Coen and Adam S. Feldman. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, The Journal of Urology, Cancer and Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact